vestronidase alfa
Selected indexed studies
- Vestronidase Alfa. (, 2006) [PMID:30000015]
- Vestronidase Alfa: A Review in Mucopolysaccharidosis VII. (BioDrugs, 2019) [PMID:30848434]
- Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII. (Mol Genet Metab, 2020) [PMID:32192868]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Vestronidase Alfa. (2006) pubmed
- Vestronidase Alfa: A Review in Mucopolysaccharidosis VII. (2019) pubmed
- Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII. (2020) pubmed
- Correction to: Vestronidase Alfa: A Review in Mucopolysaccharidosis VII. (2019) pubmed
- Open-label phase 1/2 study of vestronidase alfa for mucopolysaccharidosis VII. (2021) pubmed
- The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII. (2020) pubmed
- Mucopolysaccharidosis Type VII. (1993) pubmed
- Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program. (2024) pubmed
- Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects < 5 years with mucopolysaccharidosis VII. (2022) pubmed
- Pharmaceutical Approval Update. (2018) pubmed